cah-20241106
Cardinal Health, Inc.
Download
SEC Document
SEC Filing
0000721371false00007213712024-11-062024-11-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 2024
 
Cardinal Health, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Ohio 1-11373 31-0958666
(State or Other Jurisdiction
of Incorporation)
 (Commission
File Number)
 (IRS Employer
Identification No.)
7000 Cardinal Place, Dublin, Ohio 43017
(Address of Principal Executive Offices) (Zip Code)
(614) 757-5000
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common shares (without par value)CAHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨





Item 5.07.    Submission of Matters to a Vote of Security Holders.

Cardinal Health, Inc. (the "Company") held its 2024 Annual Meeting of Shareholders (the "Annual Meeting") on November 6, 2024. See the Company’s definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on September 16, 2024 and the supplements thereto (the “Proxy Statement”) for more information on the four proposals included in the Proxy Statement for the Annual Meeting.

Proposal 1. The shareholders elected the 10 nominees listed below to the Company's Board of Directors, each to serve until the 2025 Annual Meeting of Shareholders and until their successor is duly elected and qualified or until their earlier resignation, removal from office or death, and voted as follows:
NomineeForAgainstAbstainedBroker Non-Votes
Robert W. Azelby192,459,502395,126365,05521,165,756
Michelle M. Brennan191,815,6581,086,928317,09721,165,756
Sheri H. Edison192,414,107463,636341,94021,165,756
David C. Evans192,250,048619,049350,58621,165,756
Patricia A. Hemingway Hall184,775,0478,127,441317,19521,165,756
Jason M. Hollar191,703,0121,180,623336,04821,165,756
Akhil Johri192,294,225578,314347,14421,165,756
Gregory B. Kenny177,414,28715,477,787327,60921,165,756
Nancy Killefer185,176,0387,720,227323,41821,165,756
Christine A. Mundkur191,352,5871,542,731324,36521,165,756

Proposal 2. The shareholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers ("say-on-pay" vote), and voted as follows:
ForAgainstAbstainedBroker Non-Votes
172,738,56919,964,307516,80721,165,756

Proposal 3. The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent auditor for the fiscal year ending June 30, 2025, and voted as follows:
ForAgainstAbstainedBroker Non-Votes
202,732,60811,394,141258,6900

Proposal 4. The shareholders did not approve the shareholder proposal to prohibit the re-nomination of any director who fails to receive a majority vote, and voted as follows:
ForAgainstAbstainedBroker Non-Votes
36,980,168155,556,799682,71621,165,756
2


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  Cardinal Health, Inc.
(Registrant)
Date: November 7, 2024  By: /s/ Jessica L. Mayer
   Name: Jessica L. Mayer
   
Title: Chief Legal and Compliance Officer

3